NCT03477071

A 15-year Single Center Experience of Endovascular Treatment of Transplant Renal Artery Stenosis

A 15-year Single Center Experience of Endovascular Treatment of Transplant Renal Artery Stenosis: Evaluation of Post-operative Outcomes

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 1,323 (actual)
• Sponsor: Centre Hospitalier Universitaire de Nice · Academic / Other
• Sex: All
• Age: —
• Healthy volunteers: Not accepted

Summary

Stenosis of the renal graft arteries occurs in 1 to 26% of cases and can damage the graft. Endovascular treatment is first-line treatment. The main objective of this study is to identify the predictive factors of failure of peri-anastomotic.

Detailed description

The aim of this study was to evaluate the post-operative outcomes following endovascular treatment of TRAS (Transplant Renal Artery Stenosis). This retrospective, monocentric study included patients with peri-anastomotic stenosis of the renal graft from 2000 to 2017. The stenosis is defined by a reduction of at least 50% of the arterial diameter during arteriography. Technical success was defined as residual stenosis less than 30% of the arterial diameter after the procedure.

Conditions

• Unrecognized Condition

Interventions

Type	Name	Description
PROCEDURE	Angioplasty for Transplant Renal Artery Stenosis (TRAS)	The angioplasty is an endovascular treatment for artery stenosis, which could be associated with stenting or not.

Timeline

• Start date: 2010-01-01
• Primary completion: 2017-01-01
• Completion: 2017-12-01
• First posted: 2018-03-26
• Last updated: 2018-03-26